156_CD
GlaxoSmithKline_NN
Taxation_NOMZ
information_NOMZ
for_PIN
shareholders_NN
Information_NOMZ
for_PIN
shareholders_NN
US_FPP1
shareholders_NN
A_DT
summary_NN
of_PIN
the_DT
principal_JJ
tax_NN
consequences_NN
for_PIN
holders_NN
of_PIN
The_DT
following_GER
is_VPRT [BEMA]
a_DT
summary_NN
of_PIN
certain_JJ
United_NN
Kingdom_NN
taxation_NOMZ
shares_NN
and_PHC
ADRs_NN
who_WP [WHSUB]
are_VPRT
citizens_NN
or_CC
residents_NN
of_PIN
the_DT
United_NN
and_PHC
United_NN
States_NN
federal_JJ
income_NN
tax_NN
considerations_NOMZ
that_TSUB
may_POMD
be_VB
Kingdom_NN
or_CC
the_DT
United_NN
States_NN
is_VPRT [PASS]
set_VBN
out_PIN
below_PLACE
._.
It_PIT
is_VPRT [BEMA]
not_XX0
a_DT
relevant_JJ
to_PIN
a_DT
US_FPP1
holder_NN
of_PIN
shares_NN
or_CC
ADRs_NN
._.
This_DEMO
summary_NN
only_DWNT
complete_JJ
analysis_NN
of_PIN
all_QUAN
the_DT
possible_JJ
tax_NN
consequences_NN
of_PIN
applies_VPRT
to_PIN
a_DT
shareholder_NN
that_TSUB
holds_VPRT [PRIV]
shares_NN
or_CC
ADRs_NN
as_IN
capital_NN
purchase_NN
or_CC
ownership_NN
of_PIN
these_DEMO
securities_NOMZ
._.
assets_NN
,_,
is_VPRT [BEMA]
a_DT
citizen_NN
or_CC
resident_NN
of_PIN
the_DT
United_NN
States_NN
or_CC
a_DT
domestic_JJ
corporation_NOMZ
or_CC
that_DEMP
is_VPRT [BEMA]
otherwise_CONJ
subject_PRED
to_PIN
United_NN
States_NN
federal_JJ
Shareholders_NN
who_WP [WHSUB]
are_VPRT [BEMA]
subject_PRED
to_PIN
special_JJ
rules_NN
or_CC
who_WP
are_VPRT [BEMA]
in_PIN
any_QUAN
income_NN
taxation_NOMZ
on_PIN
a_DT
net_JJ
income_NN
basis_NN
in_PIN
respect_NN
of_PIN
the_DT
shares_NN
or_CC
doubt_NN
about_IN
their_TPP3
taxation_NOMZ
position_NOMZ
should_NEMD
consult_VB
their_TPP3
own_JJ
ADRs_NN
,_,
and_ANDC
is_VPRT [BEMA]
not_XX0
resident_PRED
in_PIN
the_DT
United_NN
Kingdom_NN
for_PIN
UK_NN
tax_NN
professional_JJ
advisors_NN
._.
purposes_NN
and_CC
does_VPRT
not_XX0
hold_VB [PRIV]
shares_NN
for_PIN
the_DT
purposes_NN
of_PIN
a_DT
trade_NN
,_,
The_DT
new_JJ
UK_NN
US_FPP1
Income_NN
Tax_NN
Convention_NOMZ
was_VBD [PASS]
signed_VBN
on_PIN
profession_NN
or_CC
vocation_NOMZ
that_DEMP
is_VPRT [PASS]
carried_VBN
on_PIN
in_PIN
the_DT
United_NN
Kingdom_NN
24th_JJ
July_NN
2001_CD
._.
However_CONJ
no_SYNE
date_NN
has_VPRT [SPAU] [PEAS]
yet_RB
been_VBN [PASS]
set_VBN
for_PIN
ratification_NOMZ
._.
The_DT
statements_NOMZ
regarding_VBG [WZPRES]
the_DT
United_NN
Kingdom_NN
and_CC
the_DT
United_NN
States_NN
tax_NN
laws_NN
and_PHC
practices_NN
set_VBN [WZPAST]
out_PIN
below_PLACE
are_VPRT [PASS]
based_VBN
on_PIN
those_DEMO
Taxation_NOMZ
of_PIN
dividends_NN
laws_NN
and_PHC
practices_NN
in_PIN
force_NN
on_PIN
the_DT
date_NN
of_PIN
this_DEMO
report_NN
._.
The_DT
gross_JJ
amount_NN
of_PIN
dividends_NN
received_VBD
including_VBG
amounts_NN
in_PIN
respect_NN
of_PIN
associated_VBN
tax_NN
credit_NN
and_PHC
UK_NN
withholding_GER
tax_NN
is_VPRT [PASS]
treated_VBN
US_FPP1
holders_NN
of_PIN
ADRs_NN
generally_RB
will_PRMD
be_VB [PASS]
treated_VBN
as_IN
the_DT
owners_NN
of_PIN
the_DT
as_IN
foreign_JJ
source_NN
dividend_NN
income_NN
for_PIN
US_FPP1
tax_NN
purposes_NN
._.
It_PIT
is_VPRT
not_XX0
underlying_VBG
shares_NN
for_PIN
the_DT
purposes_NN
of_PIN
the_DT
current_JJ
United_NN
eligible_NN
for_PIN
the_DT
dividend_NN
received_VBN
deduction_NOMZ
allowed_VBN [SUAV] [WZPAST]
to_PIN
US_FPP1
States_NN
United_NN
Kingdom_NN
double_JJ
taxation_NOMZ
conventions_NOMZ
relating_VBG [WZPRES]
to_PIN
corporations_NOMZ
._.
Dividends_NN
on_PIN
ADRs_NN
are_VPRT [BEMA]
payable_PRED
in_PIN
US_FPP1
Dollars_NN
:_:
income_NN
and_PHC
gains_NN
Income_NN
Tax_NN
Convention_NOMZ
,_,
estate_NN
and_PHC
gift_NN
taxes_NN
dividends_NN
on_PIN
shares_NN
are_VPRT [BEMA]
payable_PRED
in_PIN
pounds_NN
Sterling_GER
._.
Dividends_NN
Estate_NN
and_PHC
Gift_NN
Tax_NN
Convention_NOMZ
and_CC
for_PIN
the_DT
purposes_NN
of_PIN
the_DT
US_FPP1
paid_VBD
in_PIN
pounds_NN
Sterling_GER
will_PRMD
be_VB [PASS]
included_VBN
in_PIN
income_NN
in_PIN
the_DT
US_FPP1
Internal_NN
Revenue_NN
Code_NN
of_PIN
1986_CD
,_,
as_IN
amended_VBN
the_DT
Code_NN
._.
Dollar_NN
amount_NN
calculated_VBN [PRIV] [WZPAST]
by_PIN
reference_NN
to_PIN
the_DT
exchange_NN
rate_NN
on_PIN
The_DT
following_VBG
analysis_NN
deals_NN
with_PIN
dividends_NN
paid_VBN
after_IN
the_DT
day_NN
the_DT
dividends_NN
are_VPRT [BYPA]
received_VBN
by_PIN
the_DT
holder_NN
._.
Advance_NN
Corporation_NOMZ
Tax_NN
ACT_NN
was_VBD [PASS]
abolished_VBN
for_PIN
benefits_NN
under_IN
the_DT
current_JJ
income_NN
tax_NN
convention_NOMZ
between_PIN
for_PIN
dividends_NN
paid_VBN [WZPAST]
on_PIN
or_CC
after_IN
that_DEMO
date_NN
._.
the_DT
United_NN
States_NN
and_CC
the_DT
United_NN
Kingdom_NN
,_,
they_TPP3
may_POMD
be_VB [BEMA]
eligible_PRED
,_,
subject_JJ
to_TO
generally_RB
applicable_JJ
limitations_NOMZ
,_,
to_TO
receive_VB
a_DT
special_JJ
US_FPP1
UK_NN
shareholders_NN
foreign_JJ
tax_NN
credit_NN
equal_JJ
to_PIN
one-ninth_NN
of_PIN
the_DT
amount_NN
of_PIN
cash_NN
dividends_NN
that_TOBJ
they_TPP3
receive_VPRT
on_PIN
the_DT
shares_NN
,_,
so_RB
long_RB
as_IN
they_TPP3
make_VPRT
Taxation_NOMZ
of_PIN
dividends_NN
an_DT
election_NOMZ
to_TO
include_VB
in_PIN
their_TPP3
income_NN
,_,
as_IN
an_DT
additional_JJ
notional_NN
From_PIN
6th_JJ
April_NN
1999_CD
,_,
the_DT
rate_NN
of_PIN
tax_NN
credits_NN
was_VBD [PASS]
reduced_VBN
to_PIN
one_CD
dividend_NN
,_,
an_DT
amount_NN
equal_JJ
to_PIN
the_DT
tax_NN
credit_NN
._.
As_CONJ
a_NULL
result_NULL
of_PIN
compensating_VBG
reductions_NOMZ
in_PIN
the_DT
rate_NN
of_PIN
tax_NN
tax_NN
position_NOMZ
will_PRMD
determine_VB [SUAV] [PRIV]
whether_IN [WHCL]
effective_JJ
use_NN
can_POMD
be_VB [PASS]
made_VBN
of_PIN
on_PIN
dividend_NN
income_NN
,_,
there_EX
is_VPRT
no_SYNE
increase_NN
in_PIN
the_DT
tax_NN
borne_VBN [WZPAST]
by_PIN
UK_NN
special_JJ
US_FPP1
foreign_JJ
tax_NN
credits_NN
against_PIN
the_DT
US_FPP1
tax_NN
liability_NOMZ
._.
Tax_NN
credits_NN
are_VPRT
,_,
however_CONJ
,_,
no_SYNE
longer_JJ
repayable_JJ
to_PIN
shareholders_NN
with_PIN
a_DT
tax_NN
liability_NOMZ
of_PIN
less_JJ
than_PIN
From_PIN
6th_JJ
April_NN
1999_CD
,_,
the_DT
rate_NN
of_PIN
tax_NN
credits_NN
was_VBD [PASS]
reduced_VBN
to_PIN
one_CD
the_DT
associated_VBN
tax_NN
credit_NN
._.
ninth_JJ
and_CC
ACT_NN
was_VBD [PASS]
abolished_VBN
._.
Consequently_CONJ
,_,
claims_NN
for_PIN
refunds_NN
of_PIN
tax_NN
credits_NN
on_PIN
dividends_NN
paid_VBN [WZPAST]
on_PIN
or_CC
after_IN
this_DEMO
date_NN
are_VPRT [BEMA]
now_TIME
of_PIN
Taxation_NOMZ
of_PIN
capital_NN
gains_NN
negligible_JJ
benefit_NN
to_PIN
US_FPP1
shareholders_NN
._.
UK_NN
shareholders_NN
may_POMD
be_VB [BEMA]
liable_PRED
for_PIN
UK_NN
tax_NN
on_PIN
gains_NN
on_PIN
the_DT
disposal_NN
of_PIN
shares_NN
or_CC
ADRs_NN
._.
They_TPP3
may_POMD [SPAU]
also_RB
be_VB [PASS]
entitled_VBN
to_PIN
Taxation_NOMZ
of_PIN
capital_NN
gains_NN
indexation_NOMZ
relief_NN
and_CC
taper_VB
relief_NN
on_PIN
such_JJ
sales_NN
._.
Indexation_NOMZ
relief_NN
is_VPRT
Generally_RB
,_,
US_FPP1
holders_NN
will_PRMD
not_XX0
be_VB [BEMA]
subject_PRED
to_PIN
UK_NN
capital_NN
gains_NN
tax_NN
,_,
calculated_VBN [PRIV] [PASTP]
on_PIN
the_DT
market_NN
value_NN
of_PIN
shares_NN
at_PIN
31st_CD
March_NN
1982_CD
and_CC
but_CC
will_PRMD
be_VB [BEMA]
subject_PRED
to_PIN
US_FPP1
tax_NN
on_PIN
capital_NN
gains_NN
realized_VBN [PRIV] [WZPAST]
on_PIN
the_DT
sale_NN
on_PIN
the_DT
cost_NN
of_PIN
any_QUAN
subsequent_JJ
purchases_NN
from_PIN
the_DT
date_NN
of_PIN
such_JJ
or_CC
other_JJ
disposal_NN
of_PIN
shares_NN
or_CC
ADRs_NN
._.
Indexation_NOMZ
relief_NN
for_PIN
individual_JJ
shareholders_NN
ceased_VBD
on_PIN
Estate_NN
and_PHC
gift_NN
taxes_NN
5th_JJ
April_NN
1998_CD
._.
Taper_VB
relief_NN
is_VPRT [BEMA]
available_PRED
to_PIN
individual_JJ
shareholders_NN
Under_IN
the_DT
Estate_NN
and_PHC
Gift_NN
Tax_NN
Convention_NOMZ
,_,
a_DT
US_FPP1
shareholder_NN
is_VPRT
who_WP
hold_VPRT [PRIV]
or_CC
are_VPRT [PASS]
deemed_VBN [PRIV]
to_TO
hold_VB [PRIV]
shares_NN
for_PIN
at_PIN
least_JJ
three_CD
years_NN
not_XX0
generally_RB
subject_JJ
to_PIN
UK_NN
inheritance_NN
tax_NN
._.
Inheritance_NN
tax_NN
Stamp_NN
duty_NN
Individual_NN
shareholders_NN
may_POMD
be_VB [BEMA]
liable_PRED
to_PIN
inheritance_NN
tax_NN
on_PIN
the_DT
UK_NN
stamp_NN
duty_NN
or_CC
,_,
as_IN
the_DT
case_NN
may_POMD
be_VB
,_,
SDRT_NN
will_PRMD
,_,
subject_JJ
to_TO
transfer_VB
of_PIN
shares_NN
or_CC
ADRs_NN
._.
This_DEMO
tax_NN
may_POMD
be_VB [PASS]
charged_VBN
on_PIN
the_DT
certain_JJ
exemptions_NOMZ
,_,
be_VB [BEMA]
payable_PRED
on_PIN
any_QUAN
issue_NN
or_CC
transfer_NN
of_PIN
shares_NN
amount_NN
by_PIN
which_WDT [PIRE]
the_DT
value_NN
of_PIN
the_DT
shareholder_NN
's_POS
estate_NN
is_VPRT [PASS]
reduced_VBN
to_PIN
the_DT
ADR_NN
custodian_NN
or_CC
depository_NN
at_PIN
a_DT
rate_NN
of_PIN
1.5_CD
per_PIN
cent_NN
of_PIN
as_CONJ
a_NULL
result_NULL
of_PIN
any_QUAN
transfer_NN
by_PIN
way_NN
of_PIN
gift_NN
or_CC
other_JJ
disposal_NN
at_PIN
less_JJ
their_TPP3
price_NN
if_COND
issued_VBN
,_,
the_DT
amount_NN
of_PIN
any_QUAN
consideration_NOMZ
provided_VBD
than_PIN
full_JJ
market_NN
value_NN
._.
Exceptionally_RB
,_,
such_EMPH
a_NULL
gift_NN
or_CC
other_JJ
disposal_NN
if_COND
transferred_VBN
on_PIN
sale_NN
,_,
or_CC
their_TPP3
value_NN
if_COND
transferred_VBN
for_PIN
no_DT
is_VPRT [BEMA]
subject_PRED
to_PIN
both_DT
UK_NN
inheritance_NN
tax_NN
and_PHC
US_FPP1
estate_NN
or_CC
gift_NN
tax_NN
._.
The_DT
Estate_NN
and_PHC
Gift_NN
Tax_NN
Convention_NOMZ
would_PRMD [SPAU]
generally_RB
provide_VB
for_PIN
No_SYNE
SDRT_NN
would_PRMD
be_VB [BEMA]
payable_PRED
on_PIN
the_DT
transfer_NN
of_PIN
an_DT
ADR_NN
._.
No_SYNE
UK_NN
tax_NN
paid_VBN [WZPAST]
in_PIN
the_DT
United_NN
States_NN
to_TO
be_VB [PASS]
credited_VBN
against_PIN
tax_NN
payable_JJ
in_PIN
stamp_NN
duty_NN
should_NEMD
be_VB [BEMA]
payable_PRED
on_PIN
the_DT
transfer_NN
of_PIN
an_DT
ADR_NN
provided_VBD
the_DT
United_NN
Kingdom_NN
._.
that_THVC
the_DT
instrument_NOMZ
of_PIN
transfer_NN
is_VPRT [PASS]
executed_VBN
and_PHC
remains_VPRT
at_PIN
all_QUAN
times_NN
outside_PLACE
the_DT
UK_NN
._.
Any_QUAN
stamp_NN
duty_NN
on_PIN
the_DT
transfer_NN
of_PIN
an_DT
ADR_NN
Stamp_NN
duty_NN
would_PRMD
be_VB [BEMA]
payable_PRED
at_PIN
a_DT
rate_NN
of_PIN
0.5_CD
per_PIN
cent_NN
of_PIN
the_DT
consideration_NOMZ
UK_NN
stamp_VB
duty_NN
or_CC
,_,
as_IN
the_DT
case_NN
may_POMD
be_VB
,_,
stamp_VB
duty_NN
reserve_NN
tax_NN
for_PIN
the_DT
transfer_NN
._.
Any_QUAN
sale_NN
of_PIN
the_DT
underlying_JJ
shares_NN
would_PRMD
result_VB
in_PIN
SDRT_NN
will_PRMD
,_,
subject_JJ
to_PIN
certain_JJ
exemptions_NOMZ
,_,
be_VB [BEMA]
payable_PRED
on_PIN
the_DT
liability_NOMZ
to_PIN
UK_NN
stamp_VB
duty_NN
or_CC
,_,
as_IN
the_DT
case_NN
may_POMD
be_VB
,_,
SDRT_NN
at_PIN
a_DT
rate_NN
purchase_NN
of_PIN
shares_NN
at_PIN
a_DT
rate_NN
of_PIN
0.5_CD
per_PIN
cent_NN
of_PIN
the_DT
purchase_NN
price_NN
._.
There_EX
is_VPRT
a_DT
minimum_JJ
charge_NN
of_PIN
5_CD
where_RB
a_DT
stamp_NN
There_EX
is_VPRT
a_DT
minimum_JJ
charge_NN
of_PIN
5_CD
where_RB
a_DT
stamp_NN
duty_NN
liability_NOMZ
duty_NN
liability_NOMZ
arises_VPRT
._.
GlaxoSmithKline_NN
157_CD
Cross_NN
reference_NN
to_PIN
Form_NN
20-F_NN
This_DEMO
table_NN
has_VPRT [PEAS]
been_VBN [PASS]
provided_VBN
as_IN
a_DT
cross_NN
reference_NN
from_PIN
the_DT
information_NOMZ
included_VBD
in_PIN
this_DEMO
Annual_JJ
Report_NN
to_PIN
the_DT
requirements_NOMZ
of_PIN
Form_NN
20-F_NN
._.
Item_NN
Page_NN
Item_NN
Page_NN
1_CD
Identity_NOMZ
of_PIN
directors_NN
,_,
senior_JJ
management_NOMZ
and_PHC
advisors_NN
n_VPRT
a_DT
8_CD
Financial_NN
information_NOMZ
A_DT
Consolidated_NN
statements_NOMZ
and_CC
other_JJ
financial_JJ
information_NOMZ
2_CD
Offer_NN
statistics_NN
and_CC
expected_VBN [PRIV]
timetable_NN
n_NN
a_DT
Financial_NN
statements_NOMZ
See_VB [PRIV]
Item_NN
18_CD
3_CD
Key_NN
information_NOMZ
Legal_NN
proceedings_GER
103-107_CD
A_DT
Selected_VBN
financial_JJ
data_NN
71_CD
B_NN
Significant_JJ
changes_NN
n_VPRT
a_DT
D_NN
Risk_NN
factors_NN
64-65_CD
9_CD
The_DT
offer_NN
and_PHC
listing_GER
4_CD
Information_NOMZ
on_PIN
the_DT
company_NN
A_DT
Share_NN
price_NN
history_NN
154_CD
A_DT
History_NN
and_PHC
development_NOMZ
of_PIN
the_DT
company_NN
06_CD
C_NN
Markets_NN
154_CD
B_NN
Business_NOMZ
overview_VBD
10_CD
Additional_JJ
information_NOMZ
Products_NN
07-09_CD
B_NN
Memorandum_NN
and_PHC
Articles_NN
of_PIN
Association_NOMZ
Footnote_NN
i_FPP1
Competition_NOMZ
10-11_CD
C_NN
Material_NN
contracts_NN
n_VPRT
a_DT
Regulation_NOMZ
11-12_CD
D_NN
Exchange_NN
controls_VPRT
155_CD
Marketing_GER
and_PHC
distribution_NOMZ
13_CD
E_NN
Taxation_NOMZ
156_CD
Manufacture_NN
and_PHC
supply_NN
13-14_CD
H_NN
Documents_NOMZ
on_PIN
display_NN
38_CD
Research_NN
and_PHC
development_NOMZ
14-22_CD
Intellectual_NN
property_NN
23_CD
11_CD
Quantitative_JJ
and_PHC
qualitative_JJ
disclosures_NN
about_IN
market_NN
risk_NN
Information_NOMZ
technology_NN
24_CD
Treasury_NN
policies_NN
62-63_CD
Environment_NOMZ
,_,
health_NN
and_PHC
safety_NN
26_CD
Note_NN
32_CD
-_:
Financial_NN
instruments_NOMZ
and_CC
related_VBN
disclosures_NN
110-113_CD
Access_NN
to_PIN
medicines_NN
in_PIN
the_DT
developing_VBG
world_NN
27_CD
12_CD
Description_NOMZ
of_PIN
securities_NOMZ
other_JJ
than_PIN
equity_NOMZ
securities_NOMZ
n_VPRT
a_DT
Global_JJ
community_NOMZ
partnerships_NN
27-29_JJ
13_CD
Defaults_NN
,_,
dividend_NN
arrearages_NN
and_PHC
delinquencies_NN
n_VPRT
a_DT
C_NN
Organisational_NN
structure_NN
139-141_CD
14_CD
Material_NN
modifications_NOMZ
to_PIN
the_DT
rights_NN
of_PIN
security_NOMZ
holders_NN
D_NN
Property_NN
,_,
plant_NN
and_PHC
equipment_NOMZ
25_CD
and_CC
use_NN
of_PIN
proceeds_NN
n_VPRT
a_DT
Environmental_JJ
responsibility_NOMZ
26_CD
Note_NN
6_CD
Segment_NOMZ
information_NOMZ
86-88_CD
15_CD
Controls_NN
and_PHC
procedures_NN
35-38_CD
Note_NN
17_CD
Tangible_JJ
fixed_JJ
assets_NN
96_CD
16_CD
Reserved_VBN
5_CD
Operating_GER
and_CC
financial_JJ
review_NN
and_PHC
prospects_NN
17_CD
Financial_NN
statements_NOMZ
n_VPRT
a_DT
A_DT
Operating_GER
results_NN
18_CD
Financial_NN
statements_NOMZ
2002_CD
and_CC
2001_CD
53-65_CD
Directors_NN
statements_NOMZ
of_PIN
responsibility_NOMZ
74_CD
2001_CD
and_CC
2000_CD
66-70_CD
Independent_NN
auditors_NN
report_VPRT [PUBV]
75_CD
Under_IN
US_FPP1
accounting_GER
principles_NN
72_CD
Consolidated_NN
statement_NOMZ
of_PIN
profit_NN
and_PHC
loss_NN
76-77_CD
B_NN
Liquidity_NOMZ
and_PHC
capital_NN
resources_NN
60-65_CD
Consolidated_NN
statement_NOMZ
of_PIN
total_JJ
recognized_VBN [PRIV]
gains_NN
and_PHC
losses_NN
76-77_CD
C_NN
Research_NN
and_PHC
development_NOMZ
,_,
patents_NN
and_PHC
licenses_NN
,_,
etc._FW
._.
14-22_CD
,52_CD
Consolidated_NN
statement_NOMZ
of_PIN
cash_NN
flow_NN
78-79_CD
D_NN
Trend_NN
information_NOMZ
52_CD
Consolidated_NN
balance_NN
sheet_NN
80_CD
6_CD
Directors_NN
,_,
senior_JJ
management_NOMZ
and_PHC
employees_NN
Reconciliation_NOMZ
of_PIN
movements_NOMZ
in_PIN
equity_NOMZ
shareholders_NN
funds_NN
80_CD
A_DT
Directors_NN
and_CC
senior_JJ
management_NOMZ
32-33_CD
Company_NN
balance_NN
sheet_NN
81_CD
B_NN
Compensation_NOMZ
Notes_NN
to_PIN
the_DT
financial_JJ
statements_NOMZ
82-141_CD
Remuneration_NOMZ
report_NN
39-50_CD
19_CD
Exhibits_NN
C_NN
Board_NN
practices_NN
Corporate_JJ
governance_NN
34-38_CD
Footnote_NN
i_FPP1
D_NN
Employees_NN
Information_NOMZ
responsive_JJ
to_PIN
this_DEMO
item_NN
is_VPRT [BYPA]
incorporated_VBN
by_PIN
reference_NN
GlaxoSmithKline_NN
people_NN
24-25_CD
to_PIN
Memorandum_NN
and_PHC
Articles_NN
of_PIN
Association_NOMZ
of_PIN
GlaxoSmithKline_NN
Note_VB [PRIV]
33_CD
Employee_NN
costs_NN
114-118_CD
at_PIN
pages_NN
3536_CD
of_PIN
the_DT
Groups_NN
Annual_JJ
Report_NN
on_PIN
Form_NN
20-F_NN
for_PIN
Financial_NN
record_NN
142-150_CD
the_DT
year_NN
ended_VBD
31st_CD
December_NN
2000_CD
._.
E_NN
Share_NN
ownership_NN
GlaxoSmithKline_NN
people_NN
24-25_JJ
Note_NN
34_CD
Employee_NN
share_NN
schemes_NN
118-121_CD
Share_NN
options_NOMZ
48_CD
Incentive_NN
plans_NN
49_CD
Directors_NN
interests_NN
47,50_CD
7_CD
Major_JJ
shareholders_NN
and_CC
related_VBN
party_NN
transactions_NOMZ
A_DT
Major_JJ
shareholders_NN
155_CD
B_NN
Related_VBN
party_NN
transactions_NOMZ
38,121_CD
